These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28532498)

  • 1. The golden hour of acute ischemic stroke.
    Advani R; Naess H; Kurz MW
    Scand J Trauma Resusc Emerg Med; 2017 May; 25(1):54. PubMed ID: 28532498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delays in door-to-needle time for acute ischemic stroke in the emergency department: A comprehensive stroke center experience.
    Mowla A; Doyle J; Lail NS; Rajabzadeh-Oghaz H; Deline C; Shirani P; Ching M; Crumlish A; Steck DA; Janicke D; Levy EI; Sawyer RN
    J Neurol Sci; 2017 May; 376():102-105. PubMed ID: 28431590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal sustainability of guideline based door-to-needle times for intravenous thrombolysis for acute ischemic stroke.
    Raina A; Trivedi M; Kate M; Kumar L; Erat Sreedharan S; Sylaja PN
    J Clin Neurosci; 2020 Apr; 74():164-167. PubMed ID: 32094070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
    Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
    J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous thrombolysis for ischemic stroke in the golden hour: propensity-matched analysis from the SITS-EAST registry.
    Tsivgoulis G; Katsanos AH; Kadlecová P; Czlonkowska A; Kobayashi A; Brozman M; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Liantinioti C; Giannopoulos S; Mikulik R
    J Neurol; 2017 May; 264(5):912-920. PubMed ID: 28315960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with in-hospital delays in treating acute stroke with intravenous thrombolysis in a tertiary centre.
    Iglesias Mohedano AM; García Pastor A; García Arratibel A; Sobrino García P; Díaz Otero F; Romero Delgado F; Domínguez Rubio R; Muñoz González A; Vázquez Alen P; Fernández Bullido Y; Villanueva Osorio JA; Gil Núñez A
    Neurologia; 2016 Sep; 31(7):452-8. PubMed ID: 25660140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.
    Kim DH; Cha JK; Park HS; Choi JH; Kang MJ; Huh JT
    J Clin Neurosci; 2014 Aug; 21(8):1428-32. PubMed ID: 24980628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of arterial occlusion on outcome after intravenous thrombolysis for acute ischemic stroke.
    Medlin F; Amiguet M; Vanacker P; Michel P
    Stroke; 2015 Jan; 46(1):126-31. PubMed ID: 25424477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and effectiveness of endovascular treatment after 6 hours of symptom onset in patients with anterior circulation ischemic stroke: a matched case control study.
    Qureshi AI; Miley JT; Chaudhry SA; Semaan E; Rodriguez GJ; Suri MF; Adams HP
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1076-81. PubMed ID: 23099041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke.
    Mansoor S; Zand R; Al-Wafai A; Wahba MN; Giraldo EA
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):969-71. PubMed ID: 22306381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with In-Hospital Delay in Intravenous Thrombolysis for Acute Ischemic Stroke: Lessons from China.
    Huang Q; Ma QF; Feng J; Cheng WY; Jia JP; Song HQ; Chang H; Wu J
    PLoS One; 2015; 10(11):e0143145. PubMed ID: 26575839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy.
    Ebinger M; Kunz A; Wendt M; Rozanski M; Winter B; Waldschmidt C; Weber J; Villringer K; Fiebach JB; Audebert HJ
    JAMA Neurol; 2015 Jan; 72(1):25-30. PubMed ID: 25402214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors.
    Van Schaik SM; Scott S; de Lau LM; Van den Berg-Vos RM; Kruyt ND
    Cerebrovasc Dis Extra; 2015; 5(2):75-83. PubMed ID: 26265910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Thrombolysis and Passes of Thrombectomy as Predictors for Endovascular Revascularization in Ischemic Stroke.
    Angermaier A; Michel P; Khaw AV; Kirsch M; Kessler C; Langner S
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2488-95. PubMed ID: 27495833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfonylurea Pretreatment and In-Hospital Use Does Not Impact Acute Ischemic Strokes (AIS) Outcomes Following Intravenous Thrombolysis.
    Tsivgoulis G; Goyal N; Iftikhar S; Zand R; Chang JJ; Elijovich L; Alexandrov AW; Malkoff MD; Alexandrov AV
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):795-800. PubMed ID: 27865697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients: Evaluation of Clinical Outcomes.
    Zhang PL; Wang YX; Chen Y; Zhang CH; Li CH; Dong Z; Yin H; Zhang FF; Wang JH
    Cell Biochem Biophys; 2015 May; 72(1):11-7. PubMed ID: 25552251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.